Email address
[email protected]Contact number
1 202 663 6096Share profile
Band 2
Provided by Amy Wigmore
Amy Wigmore is a first-chair trial lawyer with more than 20 years of experience managing complex litigation, focusing primarily on technology disputes. She is a member of the firm's Litigation/Controversy Department and Intellectual Property Litigation Practice.
Ms. Wigmore is widely known for her trial work. She is a fellow of the Litigation Counsel of America, and she has been recognized as a leading IP Litigation practitioner by several publications, including Chambers, LMG Life Sciences, and Managing IP.
Ms. Wigmore has extensive experience representing clients in the pharmaceutical, biotechnology and medical device industries. She has participated in several jury trials and secured multiple verdicts exceeding $500 million on behalf of her clients. Ms. Wigmore also has played a leading role in bench trials, arbitrations and appellate matters.
In addition to her patent litigation experience, Ms. Wigmore has represented clients in cases involving the misappropriation of trade secrets, unfair competition, breach of contract, employment disputes, civil rights claims and test security issues.
Admissions
District of Columbia
Massachusetts
US Supreme Court
US Court of Appeals for the District of Columbia Circuit
US Court of Appeals for the Federal Circuit
US Court of Appeals for the Sixth Circuit
US District Court for the District of Colorado
US District Court for the District of Columbia
US District Court for the District of Massachusetts
Choosing the Right Verdict Form - The National Law Journal
Patent Litigation Practitioner of the Year (DC Metro Area)
Managing IP
2021
Women Worth Watching Award
Profiles in Diversity Journal
2019
Harvard Law School
JD
1995
University of Massachusetts
BA
1992
Achieved complete victory for pharmaceutical clients at trial and on appeal in a Hatch-Waxman case involving multiple generic challenges to patents covering a blockbuster drug.
Participated a jury trial resulting in a $539 million damages award for a technology client.
Represent pharmaceutical company in defending against a challenge to patents covering a blockbuster oncology drug.
Represent biotechnology company in multiple appeals concerning patents relating to vaccine formulation.
Secured a victory for a pharmaceutical company in a jury trial on patent validity and obtained a $2.15 billion settlement for patent infringement damages resulting from an “at-risk” launch of a generic pharmaceutical product.
Represented a biotechnology company in a highly successful five-year legal battle involving a licensing dispute with a major clinical diagnostics company. The 10-week jury trial resulted in a $505 million verdict for our client and ultimately led to a $1.4 billion acquisition of our client by the defendant.
Represented a major pharmaceutical company in multiple jury trials, bench trials, and US and international arbitrations involving biotechnology patents.
Achieved a favorable jury verdict for a medical device company in patent litigation concerning safety needles and blood collection devices.
Successfully argued on behalf of a pharmaceutical company for dismissal of patent infringement allegations concerning a biotechnology patent on the grounds that the asserted claims were unpatentable.
Served as lead counsel for a power wheelchair manufacturer in defending against patent infringement allegations.
Represented a medical device company in defending a patent infringement case involving surgical ablation devices.
Successfully argued in the Federal Circuit for dismissal of the appeal of an inter partes reexam in which the patent claims asserted against a medical device manufacturer were found invalid.
Represented a pharmaceutical company in the appeals of Hatch-Waxman cases involving treatments for Hepatitis C and HIV.
Successfully represented a pharmaceutical company in a Hatch-Waxman patent infringement case involving a treatment for HIV.
Served as lead counsel in a patent infringement case involving biotechnology.
Served as lead counsel for the defendant in a patent infringement case concerning digital audio technology.
Represented a pharmaceutical company in a license dispute concerning drug-eluting stents.
Successfully represented a pharmaceutical company in a Hatch-Waxman patent infringement case involving a treatment for Parkinson's disease.
Provided by Chambers
Provided by Chambers
She is a sharp, smart and sophisticated litigator.
Amy is extremely professional in everything she does.
She is good with strategy and really well-versed in the law.
Amy is a sharp, thoughtful and highly collaborative partner whose strategic insight and responsiveness make her an exceptional outside counsel.
She is a sharp, smart and sophisticated litigator.
Amy is extremely professional in everything she does.
She is good with strategy and really well-versed in the law.
Amy is a sharp, thoughtful and highly collaborative partner whose strategic insight and responsiveness make her an exceptional outside counsel.